Latest Commercial Trials News

Adisyn Ltd has initiated a pivotal phase in its graphene interconnect technology development, commissioning a state-of-the-art Atomic Layer Deposition system and collaborating globally to tackle semiconductor bottlenecks.

Green360 Technologies has made significant strides in low-carbon cement development through a joint venture with PERMAcast and reported strong financial growth at its Pittong kaolin operations. The company is progressing towards commercial-scale production of sustainable building materials while expanding into new markets.

Sprintex Limited has extended convertible note and loan agreements totaling A$2.85 million, bolstering financial flexibility as it prepares for a significant sales trial with the Van Drie Group that could unlock over A$8.5 million in revenue.

Green360 Technologies has developed a proprietary low-carbon cement blend using red mud and kaolin, achieving significant reductions in hazardous leachates and competitive strength performance. The company is poised to begin commercial-scale validation with JV partner PERMAcast.

Green360 Technologies has successfully produced high-quality metakaolin from its kaolin resources, surpassing industry benchmarks and initiating commercial-scale trials with PERMAcast to validate its low-carbon cement formulations.

Avecho Biotechnology has expanded its pivotal Phase III clinical trial for a CBD insomnia treatment by adding new recruitment sites and partnering with pharmaceutical giant Sandoz to boost patient enrolment and regulatory progress.

First Graphene has secured a multi-year exclusive deal to supply graphene-enhanced masterbatch for safety boots aimed at Southeast Asia’s mining sector, marking a significant step in commercialising advanced materials in industrial apparel.

Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.

InteliCare Holdings has secured a new commercial trial with mecwacare and advanced deployments at Hardi Aged Care sites, underpinning growth in its AI-driven aged care platform amid regulatory changes.

Zoono Group Limited reports strong progress in its shelf-life extension technology trials across multiple continents, with successful UK supermarket trials paving the way for a national roll-out in FY26. Despite a quarterly operating cash outflow, the company expects improved sales and sufficient funding to meet its near-term objectives.

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.